VRTX Bruce I Sachs buys $1.9M worth of shares
Aug 08, 2025, 10:32 AM
0.00%
What does VRTX do
Vertex Pharmaceuticals, headquartered in Boston, specializes in developing small molecule drugs for serious diseases, with four approved cystic fibrosis treatments and therapies for sickle cell disease. The company employs 5,400 people and explores innovative treatments for various conditions, including type 1 diabetes.
Bruce I Sachs bought 5,000 shares of VRTX on 6 August at $389.84 per share, worth a total of $1.9M. They now own 45,000 VRTX shares, or a 13% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.